Brief: Arocell Signs Additional Agreement With Zecen Biotech

IDL Diagnostics AB (publ)

17/07/2023 09:53

July 17 (Reuters) - AroCell AB (publ)  AROC.ST :
    * ADDITIONAL AGREEMENT WITH ZECEN BIOTECH FOR DEVELOPMENT OF
COMPANY'S THIRD TUMOR MARKER PRODUCT, TK 210 ELISA

Source text for Eikon:  ID:nMFN2LLZ 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))